Researchers develop framework for value-based pricing of cancer drugs
At a time when cancer drug prices are rising rapidly, an innovative new study provides the framework for establishing value-based pricing for all new oncology drugs entering the marketplace. Using a highly sophisticated economic model, researchers from Winship Cancer Institute of Emory University and Georgia Institute of Technology used an example of a new lung cancer drug. The study findings will be published August 27, 2015 in JAMA Oncology.
Researchers focused their investigation on a drug called necitumumab, which is awaiting approval from the U.S. Food and Drug ...



